Interactions between the immune system and skin bacteria are of major importance in the
pathophysiology of atopic dermatitis (AD), yet our understanding of them is limited. From a …

Atopic dermatitis is a chronic inflammatory skin condition with drastic impacts on pediatric
health. The pathogenesis of this common disease is not well understood, and the complex …

Background Alterations of the skin microbiome have been associated with atopic dermatitis
(AD) and its severity. The nasal microbiome in relation to AD severity is less well studied …

abstract Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects 15e20% of
children and 2e5% of adults in industrialized countries. The pathogen Staphylococcus …

Background Atopic dermatitis (AD) is characterized by an altered skin microbiome
dominantly colonized by S. aureus. Standard treatment includes emollients, anti …

The heterogeneous course, severity, and treatment responses among patients with atopic
dermatitis (AD; eczema) highlight the complexity of this multifactorial disease. Prior studies …

Atopic dermatitis (AD) is a chronic inflammatory skin disease predominantly mediated by T
helper cells. While numerous adaptive immune mechanisms in AD pathophysiology have …

Atopic dermatitis (AD) is associated with cutaneous dysbiosis, barrier defects, and immune
dysregulation, but the interplay between these factors needs further study. Early-onset …

A dysfunctional epidermal barrier, which may be associated with mutations in the filaggrin
gene in genetically predisposed individuals or harmful effects of environmental agents and …

Atopic dermatitis (AD) is a common inflammatory skin disease associated with significant
medical burden, affecting 15% to 20% of children and 1% to 3% of adults worldwide. 1 The …